| scholarly article | Q13442814 |
| P2093 | author name string | D Lillicrap | |
| P D James | |||
| J Grabell | |||
| N Rydz | |||
| P2860 | cites work | Hemostasis factors and aging | Q33299066 |
| The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study | Q34595035 | ||
| Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study | Q35582687 | ||
| Hemostasis and aging | Q36543985 | ||
| von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). | Q37100261 | ||
| Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. | Q44855885 | ||
| Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease | Q45145414 | ||
| Health status and health‐related quality of life associated with von Willebrand disease | Q45862315 | ||
| Comorbidities and bleeding pattern in elderly haemophilia A patients | Q45885605 | ||
| Age-dependent increase of FVIII:C in mild haemophilia A. | Q45885847 | ||
| The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study | Q46776418 | ||
| Health-related quality of life among adult patients with moderate and severe von Willebrand disease | Q48852651 | ||
| Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 | ||
| The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study | Q56224977 | ||
| Seasonal changes in haemostatic factors in young and elderly subjects | Q57134599 | ||
| Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive | Q57181440 | ||
| Hemostatic response to acute physical exercise in healthy adolescents | Q58230161 | ||
| Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD) | Q59511666 | ||
| A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD) | Q59511676 | ||
| Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years | Q68041990 | ||
| Distribution of 16 hemostatic laboratory variables assayed in 100 blood donors | Q68439426 | ||
| Factor IX is activated in vivo by the tissue factor mechanism | Q68882135 | ||
| Blood coagulation factors in the elderly | Q69475742 | ||
| Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause | Q69976764 | ||
| Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study | Q72653454 | ||
| Protein C, antithrombin III and plasminogen: effect of age, sex and blood group | Q72695737 | ||
| Aging, physical conditioning, and exercise-induced changes in hemostatic factors and reaction products | Q73746483 | ||
| Impact, diagnosis and treatment of von Willebrand disease | Q74225973 | ||
| Von Willebrand factor in Italian centenarians | Q78846136 | ||
| von Willebrand factor-to-ADAMTS13 ratio increases with age in a Japanese population | Q84014384 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 636-641 | |
| P577 | publication date | 2015-03-10 | |
| P1433 | published in | Haemophilia | Q15753375 |
| P1476 | title | Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease | |
| P478 | volume | 21 |
| Q55283293 | Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms. |
| Q64240724 | Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor |
| Q45874634 | Can you grow out of von Willebrand disease? |
| Q36920462 | Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States |
| Q55617050 | Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease. |
| Q99631231 | Desmopressin responsiveness by age in type 1 von Willebrand disease |
| Q38682256 | Developments in the diagnostic procedures for von Willebrand disease. |
| Q92671832 | Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report |
| Q91675224 | Genetic regulation of plasma von Willebrand factor levels in health and disease |
| Q44385751 | Increase of von Willebrand factor with aging in type 1 von Willebrand disease: fact or fiction? |
| Q97551370 | Low VWF: insights into pathogenesis, diagnosis, and clinical management |
| Q39027900 | New treatment approaches to von Willebrand disease. |
| Q47793791 | Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels |
| Q47664550 | Outgrowing the laboratory diagnosis of type 1 von Willebrand disease: A two decade study. |
| Q39364105 | Prevalence and Risk Factors Associated With Hypertension in von Willebrand Disease. |
| Q45871569 | The Association of Aging With Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand Disease. |
| Q45855139 | Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease. |
| Q58781583 | Von Willebrand disease in the elderly: clinical perspectives |
Search more.